Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCL
Nasdaq
8731
https://www.abcellera.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbCellera Biologics Inc
2020 Canadian IPO mixed results - number (77) down, amount ($5.55B) up driven by PE-backed IPOs
- Jan 5th, 2021 2:30 pm
AbCellera-Discovered Neutralizing Antibody for COVID-19 Enters New Pragmatic Study in New Mexico
- Dec 21st, 2020 2:00 pm
AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
- Dec 16th, 2020 2:03 am
Certara IPO Soars 66%. Employees Will Get Shares.
- Dec 11th, 2020 10:39 pm
AbCellera Rockets 195%, 4D Molecular Up 76% as Flurry of Health-Care IPOs Begin Trading
- Dec 11th, 2020 10:25 pm
AbCellera Announces Pricing of Initial Public Offering
- Dec 11th, 2020 3:47 am
Scroll